Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Patients With Multiple Sclerosis
Clinical trial NCT01933802 · COMPLETED
Trial details
- NCT number
- NCT01933802
- Sponsor
- Tisch Multiple Sclerosis Research Center of New York
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-01
- Primary completion
- 2016-12-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.